{"entity":{"id":"catheter-securement-devices","kind":"technology","name":"Catheter securement devices and dressings (SecurAcath, Tegaderm CHG)","aka":["Subcutaneous catheter securement","SecurAcath","Tegaderm CHG","Chlorhexidine gel dressing","Catheter securement"],"tldr":"Ways of holding a PICC or central line in place without stitches: a small anchor that sits just under the skin, or a see-through dressing containing an antiseptic gel that also helps keep infection away.","summary":"NICE recommends SecurAcath \"as a cost-saving option for securing peripherally inserted central catheters (PICCs) with an anticipated medium- to long-term dwell time\" (HTG440, formerly MTG34, published 5 June 2017, updated 10 August 2022); its cost model found savings when the PICC stays in place for 21 days or longer, because the anchor does not need replacing at weekly dressing changes. SecurAcath's 510(k) (K210629, 12 April 2021, product code OKC) is for \"catheter securement to the access site by means of subcutaneous anchors\". For dressings, NICE says the case for 3M's Tegaderm CHG IV securement dressing \"is supported by the evidence\" for central venous and arterial catheter sites in critically ill adults in intensive care or high dependency units, because it reduces catheter-related bloodstream and local site infections compared with standard transparent dressings (HTG379, formerly MTG25).","status":"established","asOf":"2026-11-04","links":[{"label":"NICE HTG440: SecurAcath for securing percutaneous catheters","url":"https://www.nice.org.uk/guidance/htg440"},{"label":"FDA 510(k) K210629: SecurAcath (12 April 2021)","url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K210629"},{"label":"NICE HTG379: Tegaderm CHG securement dressing for vascular access sites in critically ill adults","url":"https://www.nice.org.uk/guidance/htg379"}],"tags":["devices-gaps-2026-11"],"related":[],"cancers":[],"sections":["chemotherapy","supportive-care","devices"],"technologies":["picc-lines","infusion-devices-vascular-access","needleless-connector-disinfecting-caps"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["central-venous-access"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo device gap fill (openFDA, accessdata.fda.gov, NICE, NHS Drug Tariff Part IX, FDA, maker and society pages)","editedOn":"2026-11-04"},"principle":"Flexible anchors deployed under the skin at the insertion site hold the catheter hub without adhesive or sutures; antiseptic dressings hold a chlorhexidine gel pad over the insertion site under a transparent film.","strengths":["Anchor does not need changing at each dressing change","Chlorhexidine dressing lowers catheter infection in intensive care (NICE)"],"limitations":["NICE's dressing recommendation is for critically ill adults, not outpatients","Anchor removal can be uncomfortable"],"since":2015},"route":"/technologies/catheter-securement-devices/","neighbours":{"section":[{"id":"chemotherapy","kind":"section","name":"Chemotherapy","route":"/fronts/chemotherapy/"},{"id":"devices","kind":"section","name":"Devices & Physical Therapies","route":"/fronts/devices/"},{"id":"supportive-care","kind":"section","name":"Supportive Care & Survivorship","route":"/fronts/supportive-care/"}],"technology":[{"id":"needleless-connector-disinfecting-caps","kind":"technology","name":"Disinfecting caps for needleless connectors (Curos)","route":"/technologies/needleless-connector-disinfecting-caps/"},{"id":"infusion-devices-vascular-access","kind":"technology","name":"Infusion pumps, ports, and ambulatory chemotherapy devices","route":"/technologies/infusion-devices-vascular-access/"},{"id":"picc-lines","kind":"technology","name":"Peripherally inserted central catheters (PICC lines)","route":"/technologies/picc-lines/"}],"term":[{"id":"central-venous-access","kind":"term","name":"Central venous access (port, PICC line)","route":"/terms/central-venous-access/"}]}}